Iktos
Iktos leverages generative AI and robotics to accelerate small-molecule drug discovery. Their platforms, Makya and Spaya, integrate AI-driven design and retrosynthesis to streamline the drug development process.
Do you work at Iktos? Claim this page for free to update its info and collect reviews.
Claim this pageAbout Iktos
Iktos specializes in using generative AI and robotics to transform the drug discovery process. Their platform includes Makya, an AI tool designed for chemists to optimize compound design, and Spaya, a retrosynthesis platform that enhances the efficiency of chemical synthesis. By integrating these technologies with robotics, Iktos aims to create fully autonomous labs that significantly reduce the time required to develop new drug candidates.
